Related Experiment Video
Updated: Dec 14, 2025
04:53
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.0K
Increasing operational and scientific efficiency in clinical trials
Deirdre Kelly1, Anna Spreafico1, Lillian L Siu2
1Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
British Journal of Cancer
|July 22, 2020
Summary
Identifying and overcoming operational and scientific inefficiencies in clinical trials is key to advancing oncology drug development. Collaboration among stakeholders accelerates research, optimizing time and resources for better patient care.
Area of Science:
- Oncology
- Clinical Trials
- Drug Development
Background:
- Clinical trials face operational and scientific inefficiencies hindering oncology drug development.
- These roadblocks impede the timely advancement of new cancer therapies.
Purpose of the Study:
- To highlight the critical need for identifying and circumventing inefficiencies in oncology clinical trials.
- To emphasize the importance of stakeholder collaboration in accelerating clinical research.
Main Methods:
- This study is a conceptual analysis and synthesis of existing challenges.
- It involves reviewing common bottlenecks in clinical trial operations and scientific design.
Main Results:
- Inefficiencies in clinical trial operations and scientific design significantly slow down oncology drug development.
- Effective collaboration among pharmaceutical companies, regulatory bodies, and research institutions is essential.
Conclusions:
- Addressing operational and scientific inefficiencies is paramount for accelerating oncology drug development.
- Enhanced stakeholder collaboration is crucial for optimizing resource allocation and improving patient outcomes in cancer research.
Related Concept Videos
01:16Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K
01:11Clinical Trials: Overview
4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
01:28Preclinical Development: Overview
5.6K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
312
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
312
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
110
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
110
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
71
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
71